Kwabena Oteng, MD
Family Medicine · Springdale, OHNPI 1811933369
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,974,913 of the $1,975,064 with a category attached, or 100.0%. 6 manufacturers reported payments, led by CSL Behring at 55.1% of the total. Among family medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,238 payments — averaging $1595.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$1.1M
- CSL Plasma Inc.$887K
- Teva Pharmaceuticals USA, Inc.$73
- Pfizer$48
- Novartis$18
- AstraZeneca$12
What the payments were for
- Consulting fees$1,974,913100%
- Food & beverage$1510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 630 | $1,087,458 |
| CSL Plasma Inc. | 599 | $887,455 |
| Teva Pharmaceuticals USA, Inc. | 5 | $73 |
| Pfizer | 2 | $48 |
| Novartis | 1 | $18 |
| AstraZeneca | 1 | $12 |
How this compares
$1,975,064 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 149 | $1,439 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 50 | $1,046 |
| Fluticasone Propionate | 102 | $759 |
| Clarithromycin | 23 | $739 |
| Ofloxacin | 14 | $683 |
| Cefdinir | 46 | $679 |
| Doxycycline Hyclate | 48 | $516 |
| Mupirocin | 65 | $332 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $296 |
| Prednisone | 157 | $292 |
| Clindamycin Hcl | 26 | $279 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 39 | $249 |
| Cephalexin | 11 | $211 |
| Hydroxyzine Hcl | 14 | $139 |
| Azithromycin | 32 | $105 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Springdale
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
- Paul HanahanPainesville$241K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.